Omeprazole, one of the most widely prescribed proton pump inhibitors (PPIs), can reduce your body’s ability to absorb several vitamins and minerals, including vitamin B12, magnesium, iron, vitamin C, zinc, and possibly calcium. The common thread is stomach acid: omeprazole works by dramatically lowering acid production, and many nutrients depend on an acidic stomach environment to be released from food and taken up by the gut. The risk grows with higher doses and longer use, but the picture is more nuanced than a simple checklist of depleted nutrients.
Vitamin B12 Is the Best-Studied Depletion
Vitamin B12 sits tightly bound to proteins in food, and your stomach needs both acid and the enzyme pepsin to pry it loose. Once freed, B12 binds to a carrier protein in the stomach’s acidic environment before eventually being absorbed further down the digestive tract.1Advances in Nutrition. Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications When omeprazole suppresses acid production, this entire chain is weakened. The B12 stays locked inside food proteins, passes through, and never gets absorbed.
A large case-control study found that people who had taken PPIs for two or more years had a meaningfully higher chance of being diagnosed with B12 deficiency. The association was dose-dependent: those on the highest daily doses had roughly double the odds of deficiency compared to non-users.2JAMA. Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B12 Deficiency B12 deficiency can take years to develop because the body stores several years’ worth in the liver, which is why short courses of omeprazole rarely cause problems. But once stores run low, the consequences range from fatigue and tingling in the hands and feet to memory problems and a type of anemia where red blood cells become abnormally large.
Magnesium Depletion and Its Consequences
Low magnesium caused by PPIs was recognized relatively recently and caught the medical community somewhat off guard. Unlike B12, which is clearly acid-dependent for absorption, the mechanism behind PPI-related magnesium loss is less straightforward. PPIs appear to interfere with the gut’s ability to absorb magnesium, though researchers are still working out exactly how.3PubMed Central. Proton pump inhibitor-induced hypomagnesemia: A new challenge
What makes magnesium depletion especially concerning is its symptom profile. Mild drops might go unnoticed or cause muscle cramps and fatigue. Severe drops can trigger muscle spasms (tetany), seizures, and dangerous heart rhythm disturbances.3PubMed Central. Proton pump inhibitor-induced hypomagnesemia: A new challenge These serious outcomes are uncommon but have been documented clearly enough that the FDA issued a safety warning about PPI-associated hypomagnesemia back in 2011. The typical pattern involves long-term use, often a year or more, before magnesium levels dip low enough to cause symptoms.
Iron Absorption Takes a Hit
Dietary iron, particularly the non-heme form found in plant foods, grains, and fortified products, relies on stomach acid to be converted into a soluble form the body can absorb. Omeprazole raises the stomach’s pH high enough that this conversion is impaired. The heme iron in meat is somewhat less affected, because it follows a different absorption pathway, but the overall result is a reduced iron supply from the diet.
A well-documented case involved a man who had taken omeprazole for 25 years and developed iron deficiency anemia attributed to reduced gastrointestinal iron absorption from long-term acid suppression.4PubMed Central. Iron Deficiency Anemia Due to the Long-term Use of a Proton Pump Inhibitor While that is an extreme duration, the case highlights something doctors sometimes miss: when someone on long-term PPIs develops unexplained iron deficiency anemia, the drug itself deserves consideration as a contributing factor, not just bleeding or dietary intake. People who already have marginal iron stores, including menstruating women and those with limited meat intake, are at higher risk.
Vitamin C and Zinc Get Less Attention
Omeprazole lowers the concentration of vitamin C in gastric juice and shifts it away from its active antioxidant form, ascorbic acid.5PubMed. Effect of proton pump inhibitors on vitamins and iron One study found that omeprazole reduced fasting gastric ascorbic acid levels from roughly 3.8 to 0.7 micrograms per milliliter.6PubMed. Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice That is a steep local decline. Whether this translates into clinically meaningful vitamin C deficiency in the bloodstream for most users is less clear, but it does alter the stomach’s internal chemistry in ways that could matter for people already eating little fruit and few vegetables.
Zinc absorption also appears to be impaired. In one study, healthy people who took supplemental zinc saw their plasma zinc levels jump by about 126 percent, while long-term PPI users taking the same supplement saw only a 37 percent increase. Even without supplements, PPI users had roughly 28 percent lower plasma zinc than controls.7PubMed Central. Proton Pump Inhibitors Interfere With Zinc Absorption and Zinc Body Stores Zinc plays a role in immune function, wound healing, and taste perception, so chronic deficiency is not trivial, even if it rarely makes headlines the way B12 or magnesium depletion does.
The Calcium and Bone Fracture Question
Calcium’s relationship with PPIs has been debated for over a decade, and the evidence is less tidy than for the nutrients discussed above. The concern is straightforward: calcium carbonate, the form of calcium in most supplements and in dairy antacids, needs an acidic stomach to dissolve properly. Suppress that acid, and less calcium may get absorbed. Whether this meaningfully weakens bones over time has been harder to prove.
Meta-analyses and case-control data suggest that long-term, high-dose PPI use is associated with a higher rate of fragility fractures, especially hip fractures.8PubMed Central. Proton Pump Inhibitors and Fractures in Adults: A Critical Appraisal and Review of the Literature A large study of postmenopausal women found that PPI users had higher rates of clinical spine fractures, wrist fractures, and total fractures, though not hip fractures specifically, and bone mineral density measurements were largely similar between users and non-users.9PubMed Central. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women’s Health Initiative
But here is where it gets interesting. A 14-year follow-up study found that after adjusting for other factors associated with fracture risk, chronic omeprazole use was not an independent risk factor for osteoporotic fractures overall. In fact, among people 85 and older, it was inversely associated with fractures.10PubMed. Different effects of chronic omeprazole use on osteoporotic fractures rate in the elderly This does not mean omeprazole protects bones; it likely means that older adults who stay on PPIs tend to be under closer medical care and may have other health factors being managed simultaneously. The takeaway is that the fracture link is real in population-level data but probably not driven purely by calcium malabsorption. Magnesium depletion and other confounding factors likely contribute too.
How Gut Changes Amplify the Problem
Beyond simply raising stomach pH, omeprazole changes the microbial landscape of the gut in ways that could affect nutrient handling. When stomach acid drops, bacteria that would normally be killed on the way down survive and colonize the intestines. Researchers have found that the gut microbiome of PPI users shifts measurably toward an oral-bacteria profile, meaning species normally confined to the mouth start showing up in the intestines.11Gut. Proton pump inhibitors affect the gut microbiome
One practical consequence of this microbial shift is small intestinal bacterial overgrowth (SIBO), a condition in which excessive bacteria in the small intestine compete for nutrients and produce gas and bloating. In one study, SIBO was detected in half of PPI users, compared to about 6 percent of healthy controls, and the rate climbed with longer treatment duration.12Clinical Gastroenterology and Hepatology. Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy SIBO can impair the absorption of fat-soluble vitamins and B12, compounding the direct effects of acid suppression. If you are on a PPI and experience persistent bloating, diarrhea, or unexplained weight loss, SIBO is worth discussing with your doctor.
Who Is Most Vulnerable
Not everyone on omeprazole will develop nutrient problems. Several factors stack the odds.
- Duration and dose: The B12 risk climbs after roughly two years of continuous use, and higher daily doses carry greater risk.2JAMA. Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B12 Deficiency Magnesium and iron deficiencies likewise tend to appear with prolonged therapy rather than short courses.
- Older adults: Most reported cases of PPI-related B12 deficiency cluster in people 65 and older, where age-related declines in nutrient absorption are already at play.13PubMed Central. Vitamin B12 Deficiency Associated with Metformin and Proton Pump Inhibitors and Their Combinations: Results from a Disproportionality and Interaction Analysis
- People also taking metformin: Metformin, widely prescribed for type 2 diabetes, independently lowers B12 absorption through a separate mechanism. Combining it with omeprazole raises the risk further, in a dose- and duration-dependent way.14The Egyptian Journal of Internal Medicine. Risk of Vitamin B12 Deficiency Associated with Proton Pump Inhibitors, Metformin, and H2 Blockers in Geriatric Patients: A Polypharmacy Perspective
- People with limited diets: If your diet is already low in iron, zinc, or vitamin C, the added absorption barrier from omeprazole can tip the balance from adequate to deficient more quickly.
Your Genetics Can Change the Picture
Omeprazole is broken down in the liver by an enzyme called CYP2C19, and genes determine how fast or slow that process is. People who metabolize omeprazole more slowly end up with higher drug levels in their blood and stronger acid suppression at the same dose. A study of people on long-term omeprazole found that those who carry a variant form of the CYP2C19 gene had significantly lower B12 levels compared to those with the standard version of the gene.15PubMed. Effect of CYP2C19 polymorphism on serum levels of vitamin B12 in patients on long-term omeprazole treatment In other words, the same 20-milligram omeprazole tablet does not suppress acid equally in everyone. Slow metabolizers experience a stronger effect and, with it, a greater risk of nutrient depletion.
This genetic variation is not rare. Roughly 2 to 15 percent of various populations are poor metabolizers, and a much larger fraction are intermediate metabolizers who process the drug somewhat slower than average. Pharmacogenomic testing is available but is not routinely ordered before starting a PPI. If you have been on omeprazole for years and are experiencing symptoms of B12 or magnesium deficiency despite a reasonable diet, your metabolism of the drug itself could be a factor worth exploring.
What the Guidelines Actually Recommend
Given the list of nutrients that omeprazole can affect, you might expect that routine blood tests are recommended for long-term users. They are not. Current evidence does not support routine screening or supplementation for vitamin and mineral deficiencies in people on short- or long-term PPI therapy.16PubMed Central. Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications The reasoning is partly statistical: while the relative risk of deficiency goes up, the absolute number of PPI users who develop clinically significant problems remains modest compared to the total user population.
That said, many clinicians take a pragmatic approach. If you have been on omeprazole for over a year, especially at a higher dose, checking B12 and magnesium levels is a low-cost, low-risk move that most doctors will agree to. Iron studies and a complete blood count can pick up iron deficiency or the large-cell anemia associated with B12 depletion. Zinc and vitamin C are tested less often but can be added if symptoms suggest a shortfall.
The broader clinical message is about re-evaluating the need for the drug itself. Many people start omeprazole for a short-term problem, such as a stomach ulcer or a bad stretch of reflux, and then stay on it indefinitely because no one ever suggests stopping. Periodic conversations about whether you still need the medication are the single most effective way to avoid nutrient depletion from PPIs.
Practical Workarounds if You Need to Stay On
For some people, omeprazole is genuinely necessary. Barrett’s esophagus, severe erosive reflux, and certain conditions requiring long-term acid suppression are real clinical indications where the benefits clearly outweigh the nutrient risks. In these cases, a few strategies can help offset the losses.
For B12, sublingual tablets and injections bypass the stomach entirely, making them effective regardless of acid levels. Oral B12 supplements in the crystalline (non-food-bound) form are also better absorbed than food-bound B12 even in the setting of acid suppression, because crystalline B12 does not need acid and pepsin to be freed from food proteins. For calcium, choosing calcium citrate instead of calcium carbonate is a common recommendation, since citrate does not require stomach acid for dissolution. For magnesium, supplementation with well-absorbed forms like magnesium glycinate can help maintain levels, though severe PPI-induced hypomagnesemia sometimes does not respond to oral supplements and may require stopping the drug.
Iron is trickier. Taking iron supplements with vitamin C can help improve absorption, and timing the iron dose for a moment when the omeprazole’s effect is weakest (several hours after the PPI dose, or on an empty stomach before the morning PPI) may offer a small edge, though formal studies on this timing strategy are limited. Zinc supplementation can partially compensate for reduced absorption, though as the earlier data showed, the response to supplementation is blunted in PPI users compared to people with normal acid levels.7PubMed Central. Proton Pump Inhibitors Interfere With Zinc Absorption and Zinc Body Stores
Why This Is Not an Argument Against All PPI Use
It is easy to read a list like this and conclude that omeprazole is dangerous and should be avoided. That oversimplifies the situation. PPIs remain among the most effective treatments for conditions that, left untreated, carry their own serious risks: esophageal strictures, bleeding ulcers, and even esophageal cancer in the case of Barrett’s esophagus. The nutrient depletion risks are real but gradual, and for most people they are manageable with awareness, periodic monitoring, and thoughtful supplementation when indicated.
The problem is not the drug itself but the way it is used. Tens of millions of prescriptions are written annually, and a substantial fraction of those are for people who no longer have a clear indication for continued acid suppression. For someone who started omeprazole five years ago for occasional heartburn and never revisited the decision, the risk-benefit balance has shifted. The nutrients at stake are ones the body needs daily, and the deficits accumulate quietly. The fix, in most cases, is not to avoid PPIs entirely but to use them at the lowest effective dose for the shortest necessary time, and to pay attention to what they quietly take away.